These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23227546)

  • 1. Synthesis and antitumor activity of novel 2-(1-substituted-piperidin-4-ylamino)quinazolines as antitumor agents.
    Wang YK; Jin J; Zhu LN; Zhang Y; Chen XG; Gao XQ; Xu BL
    Yao Xue Xue Bao; 2012 Sep; 47(9):1164-78. PubMed ID: 23227546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
    He J; Wang X; Zhao X; Liang Y; He H; Fu L
    Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
    Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
    Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.
    Li HQ; Li DD; Lu X; Xu YY; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(1):317-23. PubMed ID: 22112541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors.
    Li DD; Fang F; Li JR; Du QR; Sun J; Gong HB; Zhu HL
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5870-5. PubMed ID: 22901387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.
    Xu YY; Li SN; Yu GJ; Hu QH; Li HQ
    Bioorg Med Chem; 2013 Oct; 21(19):6084-91. PubMed ID: 23962660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of substituted benzylamino- and heterocyclylmethylamino carbodithioate derivatives of 4-(3H)-quinazolinone and their cytotoxic activity.
    Cao SL; Feng YP; Zheng XL; Jiang YY; Zhang M; Wang Y; Xu M
    Arch Pharm (Weinheim); 2006 May; 339(5):250-4. PubMed ID: 16619282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
    El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
    Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
    Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
    Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
    Luo H; Yang S; Cai Y; Peng Z; Liu T
    Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
    Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
    Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
    Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
    Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
    Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
    Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents.
    Jiang N; Zhai X; Zhao Y; Liu Y; Qi B; Tao H; Gong P
    Eur J Med Chem; 2012 Aug; 54():534-41. PubMed ID: 22727449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and antitumor activity of C3 heterocyclic-substituted fluoroquinolone derivatives (I): ciprofloxacin aminothiodiazole Schiff-bases].
    Hu GQ; Wu XK; Wang X; Zhang ZQ; Xie SQ; Huang WL; Zhang HB
    Yao Xue Xue Bao; 2008 Nov; 43(11):1112-5. PubMed ID: 19239029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM; Ashour AE
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
    Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.